Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules
Sandy Pound, Thermo Fisher's (TMO) chief communications officer ... with its 2017 acquisition of contract drugmaker Patheon ...
Thermo Fisher Scientific: Finally Ready For A Breakout? (Upgrade)
Thermo Fisher returned to growth in 4Q 2024 with 6.6% projected EPS growth. Learn why TMO stock’s leadership position and ...
Hosted on MSN11mon
Thermo Fisher Scientific (TMO) Price Target Increased by 7.66% to 607.23
including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. Fintel is one of the most comprehensive investing research platforms available to ...
PharmiWeb7d
Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...